Form Fda 3356 PDF Details

The Form FDA 3356 is a crucial document managed by the Department of Health and Human Services, specifically within the Food and Drug Administration (FDA), tailored for establishments involved with Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). This comprehensive form is meticulously designed to facilitate the registration and listing of establishments engaged in the processing, recovery, storage, labeling, packing, or distribution of HCT/Ps. It also applies to entities focused on the screening or testing of cell or tissue donors. The form, which must be submitted in adherence to regulations laid out under 21 CFR Part 1271, 207.20, and 807.20, serves multiple purposes including initial registration, annual updates, modifications to existing information, or marking an establishment as inactive. The intricacies of the form span details such as establishment and HCT/P information, including physical and mailing addresses, U.S. agent details for non-U.S. establishments, and specific types and functions of the HCT/Ps managed. Furthermore, it includes a section for proprietary names and requires explicit details regarding the establishment’s activities, whether it be recovery, processing, storage, or distribution of HCT/Ps. The necessity for accurate completion and the declaration by the reporting official underlines the form’s importance in maintaining up-to-date and factual records within the FDA’s regulatory landscape. This process not only ensures compliance with federal regulations but also supports the FDA’s mission to protect public health by supervising cell and tissue-based products, guaranteeing they are safe, effective, and available to those in need.

QuestionAnswer
Form NameForm Fda 3356
Form Length2 pages
Fillable?No
Fillable fields0
Avg. time to fill out30 sec
Other namespreprinted, Allogeneic, Rockville, CFR

Form Preview Example

See Instructions for PRA Statement. FORM APPROVED: OMB No. 0910-0543. Expiration Date: 3/31/2017

DEPARTMENT OF HEALTH AND HUMAN SERVICES

1. REGISTRATION NUMBER

2. REASON FOR SUBMISSION

VALIDATION – FOR FDA USE ONLY

FDA Establishment Identifier

 

 

 

FOOD AND DRUG ADMINISTRATION

a.

INITIAL REGISTRATION/LISTING

 

 

 

ESTABLISHMENT REGISTRATION AND LISTING FOR HUMAN CELLS, TISSUES,

 

 

 

 

 

 

b.

ANNUAL REGISTRATION/LISTING

 

 

 

 

AND CELLULAR AND TISSUE-BASED PRODUCTS (HCT/Ps)

FEI

 

 

 

 

 

c.

CHANGE IN INFORMATION

 

 

 

 

 

 

 

(See reverse side for instructions)

 

 

 

 

 

 

 

 

 

d.

INACTIVE

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

PART I – ESTABLISHMENT INFORMATION

 

 

PART II – HCT / P INFORMATION

 

 

 

 

 

11.HCT/Ps DESCRIBEDIN 21CFR1271.10

12.HCT/Ps REGULATED ASMEDICAL DEVICES

13.HCT/PsREGU LATEDASDRUGS ORBIOLOGICAL DRUGS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3. OTHER FDA REGISTRATIONS

 

 

10. ESTABLISHMENT FUNCTIONS AND TYPES OF HCT / Ps

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

14. PROPRIETARY

a. BLOOD FDA 2830

NO.

 

 

 

 

 

 

 

 

Establishment Functions

 

 

 

 

 

 

b. DEVICE FDA 2891

NO.

 

 

 

Types of HCT / Ps

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NAMES

 

 

 

Recover

Screen

Test

Package

Process

Store

 

Label

Distribute

 

 

 

 

 

 

 

 

 

 

 

 

c. DRUG FDA 2656

NO.

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

a. Bone

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4. PHYSICAL LOCATION (Include legal name, number and street, city, state,

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

country, and post office code.)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

b. Cartilage

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

c. Cornea

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

d. Dura Mater

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SIP

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

a. PHONE:

 

 

 

 

 

e. Embryo

Directed

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Anonymous

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

b.

SATELLITE RECOVERY ESTABLISHMENT

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

f. Fascia

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(MANUFACTURING ESTABLISHMENT FEI NO.

 

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

c.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TESTING FOR MICRO-ORGANISMS ONLY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

g. Heart Valve

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5. ENTER CORRECTIONS TO ITEM 4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

h. Ligament

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SIP

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

i. Oocyte

Directed

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Anonymous

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6. MAILING ADDRESS OF REPORTING OFFICIAL (Include institution name if

j. Pericardium

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

applicable, number and street, city, state, country, and post office code.)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

k. Peripheral

Autologous

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Blood Stem

Family

Related

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cells

Allogeneic

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

l. Sclera

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SIP

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

m. Semen

Directed

 

 

 

 

 

 

 

 

 

 

 

 

 

 

a. PHONE:

 

 

 

 

 

 

Anonymous

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

n. Skin

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7. ENTER CORRECTIONS TO ITEM 6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

o. Somatic Cell

Autologous

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Therapy

Family

Related

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Products

Allogeneic

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

p. Tendon

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8. U.S. AGENT

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

q. Umbilical

Autologous

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cord Blood

Family

Related

 

 

 

 

 

 

 

 

 

 

 

 

 

 

a. E-MAIL ADDRESS:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stem Cells

Allogeneic

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

b. PHONE:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

r. Vascular Graft

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

9. REPORTING OFFICIAL’S SIGNATURE

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

s.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

a. TYPED NAME:

 

 

 

 

 

t.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

b. E-MAIL ADDRESS:

 

 

 

 

 

u.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

c. TITLE:

 

 

d. DATE:

 

 

v.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FORM FDA 3356 (5/14)

PSC Publishing Services (301) 443-6740 EF

Page 1 of 2

INSTRUCTIONS FOR COMPLETING FORM 3356: ESTABLISHMENT REGISTRATION AND LISTING FOR

HUMAN CELLS, TISSUES, AND CELLULAR AND TISSUE-BASED PRODUCTS (HCT/Ps)

Completion of Form FDA 3356 is required under 21 CFR Part 1271, 207.20 and 807.20 for all establishments engaged in the recovery, processing, storage, labeling, packaging, or distribution of any HCT/P, or the screening or testing of a cell or tissue donor. After we receive your form, we will update our records and send a validated form to the reporting official.

PART I. ESTABLISHMENT INFORMATION

NOTE: You are required to register and list your HCT/Ps by submitting this form if you recover, pro- cess, store, label, package, or distribute any HCT/P, or screen or test the HCT/P donor unless one of the following exceptions applies. You are not required to submit this form if:

a.You use HCT/Ps solely for nonclinical scientific or educational purposes,

b.You remove and then implant HCT/Ps solely for autologous use during the same surgical procedure,

c.You are a carrier who accepts, receives, carries, or delivers HCT/Ps in the usual course of business as a carrier,

d.You only receive or store HCT/Ps solely for implantation, transplantation, infusion, or transfer within your facility,

e.You only recover reproductive cells or tissue and immediately transfer them into a sexually inti- mate partner of the cell or tissue donor, or

f.You are an individual person who works under contract, agreement, or other arrangement with or for a registered establishment and only recover and send HCT/Ps to the registered establishment.

Item 3. OTHER FDA REGISTRATIONS – Provide the registration number if your establishment is already registered with FDA as a Blood, Medical Device or Drug establishment. Your establishment will not be given a new registration number, and you are not required to fill in items 4 to 8 of Part I. Item 9 must be filled out and signed on all forms. If you choose not to complete Items 4 to 8 of Part I, you still must complete and sign Item 9. Then proceed to Part II and provide product information.

Item 4. PHYSICAL LOCATION – Provide the legal name, street address including the postal code of the actual location and

a. Telephone number.

b.Indicate (with an X) if you are a satellite recovery establishment that supports recovery personnel in the field by providing temporary storage for recovered HCT/Ps for shipment to your parent manufacturing establishment, but do not perform any other activities or manufacturing steps. Pro- vide the FEI NO. of your parent manufacturing establishment.

c.Indicate (with an X) if you are an establishment that performs testing of HCT/Ps for micro-organ- isms if that is the only HCT/P processing function that you perform.

Item 6. MAILING ADDRESS OF THE REPORTING OFFICIAL – Provide the reporting offcial’s mailing address including the postal code if it is different from the actual location of the establishment.

Items 8. U.S. AGENT Non-U.S. establishments only: Provide your U.S. agent name, institution name if applicable, street address, e-mail address, and telephone number. United States agent means a person residing or maintaining a place of business in the United States whom a foreign establishment designates as its agent.

Item 9. REPORTING OFFICIAL’S SIGNATURE – The reporting official as listed in Item 6 is the person appointed by the owner or operator to register the form and answer all the correspondence and inquiries relative thereto. The dated signature by the reporting official affirms that all information contained on the form is true and accurate, to the best of his or her knowledge.

PART II. HCT/P INFORMATION (If item 2.c is checked, only indicate the information being changed.)

Item 10. ESTABLISHMENT FUNCTIONS AND TYPES OF HCT/Ps – Indicate (with an X) the activity (ies) performed by the registered establishment in conjunction with the type of HCT/P that the registered establishment manufactures. Test and screen refer to the donor, not the HCT/P. For reproductive HCT/Ps, indicate whether the HCT/Ps are from sexually intimate partners (SIP), directed, or anonymous. For hematopoietic stem/progenitor cells and somatic cells, indicate whether the HCT/ Ps are autologous, family related, or allogeneic. Family related means allogeneic use in a first-degree or second-degree relative.

Item 11. LISTING FOR HCT/Ps DESCRIBED IN 21 CFR 1271.10 – To list HCT/Ps that are described in 21 CFR 1271.10 (a) indicate (with an X) each HCT/P that fulfills all of the following criteria:

a.The HCT/P is minimally manipulated,

b.The HCT/P is intended for homologous use only, as reflected by the labeling, advertising, or other indications of the manufacturer’s objective intent,

c.The manufacture of the HCT/P does not involve the combination of the cell or tissue component with a drug or a device, except for a sterilizing, preserving, or storage agent, if the addition of the agent does not raise new clinical safety concerns with respect to the HCT/P, and either

d.The HCT/P does not have a systemic effect and is not dependent upon the metabolic activity of living cells for its primary function; or the HCT/P has a systemic effect or is dependent upon the metabolic activity of living cells for its primary function, and (i) is for autologous use, (ii) is for allogeneic use in a first-degree or second-degree blood relative, or (iii) is for reproductive use.

If your HCT/P type is not preprinted on the form, list it on lines s-v.

Item 12. HCT/P LISTING FOR MEDICAL DEVICES – Indicate (with an X) each HCT/P that is regulated as a medical device under the Federal Food, Drug, and Cosmetic Act.

Item 13. HCT/P LISTING FOR DRUGS OR BIOLOGICAL DRUGS – Indicate (with an X) each HCT/ P that is regulated as a drug or biological drug under the Federal Food, Drug, and Cosmetic Act and/ or section 351 of the Public Health Service Act.

NOTE: For items 11, 12, and 13 indicate changes to HCT/P listing such as discontinuance (indicate with a D), or resumption (indicate with an R) of a HCT/P into commercial distribution in June and December or at the time the change occurs as directed under 21 CFR Part 1271.21. Dates of HCT/P discontinuance/resumption should be provided on an additional page.

Item 14. PROPRIETARY NAMES – Indicate any applicable proprietary names used for the HCT/Ps listed, such as a trademark.

NOTE: If necessary, add an additional page to complete Items 11, 12, 13, or 14.

After completion, return the form to:

Food and Drug Administration

Center for Biologics Evaluation and Research

Document Control Center

10903 New Hampshire Avenue, Building 71, Room G112

Silver Spring, MD 20993-0002

ATTENTION: Tissue Establishment Registration Coordinator

FAX No. (301) 595-1303

The information below applies only to requirements of the Paperwork Reduction Act of 1995.

The burden time for this collection of information is estimated to average .75

Department of Health and Human Services

hour per response, including the time to review instructions, search existing data

Food and Drug Administration

sources, gather and maintain the data needed and complete and review the

Office of Chief Information Officer

collection of information. Send comments regarding this burden estimate or any

Paperwork Reduction Act (PRA) Staff

other aspect of this information collection, including suggestions for reducing this

PRAStaff@fda.hhs.gov

burden to the address to the right:

 

"An agency may not conduct or sponsor, and a person is not required to respond

DO NOT SEND YOUR COMPLETED FORM

to, a collection of information unless it displays a currently valid OMB number."

TO THIS PRA STAFF EMAIL ADDRESS.

FORM FDA 3356 (5/14)

Page 2 of 2

How to Edit Form Fda 3356 Online for Free

You can work with offcial effortlessly with the help of our online tool for PDF editing. Our team is dedicated to providing you the best possible experience with our editor by consistently adding new features and enhancements. With these improvements, using our tool becomes better than ever! Getting underway is simple! All that you should do is take the next simple steps directly below:

Step 1: Press the "Get Form" button above on this page to access our editor.

Step 2: With the help of our handy PDF file editor, it is possible to accomplish more than simply fill out blank fields. Express yourself and make your forms appear perfect with customized text incorporated, or tweak the file's original input to excellence - all comes with the capability to insert your personal images and sign it off.

When it comes to blanks of this specific document, here's what you should do:

1. It's essential to complete the offcial accurately, thus be attentive when filling in the segments containing all of these blank fields:

Rockville completion process outlined (stage 1)

2. Once this array of fields is complete, you're ready to include the required specifics in MAILING ADDRESS OF REPORTING, applicable number and street city, Autologous Family Related, SIP Directed Anonymous, j Pericardium, k Peripheral, Blood Stem Cells, l Sclera, m Semen, n Skin, a PHONE, ENTER CORRECTIONS TO ITEM, US AGENT, a EMAIL ADDRESS, and b PHONE so you're able to move forward to the third part.

Completing segment 2 in Rockville

Lots of people frequently get some points incorrect while filling out Autologous Family Related in this section. You need to go over what you enter right here.

Step 3: Always make sure that the information is accurate and then simply click "Done" to continue further. Join FormsPal now and immediately use offcial, all set for download. All modifications you make are saved , which means you can modify the file later if needed. FormsPal guarantees your data privacy by using a secure method that never saves or shares any personal information used in the form. Rest assured knowing your files are kept safe every time you use our editor!